Results 31 to 40 of about 9,063 (160)

Loop-Mediated Isothermal Amplification Assay for Identifying Neisseria gonorrhoeae Nonmosaic penA-Targeting Strains Potentially Eradicable by Cefixime

Microbiology Spectrum, 2022
Treatment regimens for gonorrhea have limited efficacy worldwide due to the rapid spread of antimicrobial resistance. Cefixime (CFM) is currently not recommended as a first-line treatment for gonorrhea due to the increasing number of resistant strains ...
Ken Shimuta, Hideyuki Takahashi, Yukihiro Akeda, Shu-ichi Nakayama, Makoto Ohnishi   +4 more
doaj   +1 more source

Feasibility of the Purification of Pharmaceuticals from Aqueous Solutions using Carbon Nanotubes in the Presence of Oxidizers [PDF]

Iranian Journal of Chemical Engineering
In this research, the methods of oxidation, oxidation along with carbon nanotubes and surface absorption of carbon nanotubes were investigated to remove the drug substance of cefixime from aqueous solutions.
Faezeh Mohammadi, Negin Moradpour, Neda Azimi, Ebrahim Ebrahimi   +3 more
doaj   +1 more source

Susceptibility Pattern of Neisseria gonorrhoeae towards Cefixime and Ceftriaxone using Kirby-Bauer Method in Dr. Saiful Anwar General Hospital Malang

Berkala Ilmu Kesehatan Kulit dan Kelamin (Periodical of Dermatology and Venerology), 2020
Background: Gonorrhea remains the second most common sexually transmitted infection (STI) in the world with an increasing number of cases. Oral cefixime and IM ceftriaxone are still the mainstay therapy for gonorrhea in Indonesia.
Lita Setyowatie, Tantari SHW, Inneke Yulian   +2 more
doaj   +1 more source

CEFIXIME

The Professional Medical Journal, 2015
Cefixime is a third generation and orally acting cephalosporin. It is a cell wallsynthesis inhibitor and is well stable to presence of beta lactamase enzymes. Environmentaland genetic differences play a greater role in disposition kinetics of a drug.
Muhammad Mudassar Ashraf, Ijaz Javed, Bilal Aslam, Tanweer Khaliq   +3 more
openaire   +3 more sources

Cost Effectiveness Analysis Using Antibiotics of Cefixime and Cefotaxime for Diarrhea Patients at X Hospital in 2017

Jurnal Manajemen dan Pelayanan Farmasi, 2019
Diarrhea is a disease characterized by a change in the shape and consistency of stools, from soft to liquid, and increased frequency of bowel movements, which happen three times or more in a day.
Gayatri Citraningtyas, Ranny Inggrid Ruru, Amelia Nalang   +2 more
doaj   +1 more source

UGT1A1 genotype testing for irinotecan: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

British Journal of Clinical Pharmacology, EarlyView.
Abstract Irinotecan, a topoisomerase I inhibitor, is available as both non‐pegylated and pegylated formulations. The non‐pegylated formulation is licensed for use in advanced colorectal cancer either in combination with other agents or as monotherapy.
Dharmisha Chauhan, Cinzia Dello Russo, Jack Thompson, Dyfrig A. Hughes, Katherine Payne, Maria Tsakiroglou, Paul Ross, Rena Chauhan, Simon Jenkinson, Jessica Keen, Sophie Harding, Eleanor Lau, Michael Braun, Roshan Agarwal, Richard Adams, Elisabeth Rolf, Farah Al‐Sheikhli, Sarah Mitchell, Ruth Hammond, Rosie Roberts, Lorna Cairns, Shirley Heggarty, Janet Graham, Justin Mencel, Munir Pirmohamed   +24 more
wiley   +1 more source

Pengobatan Cefixime pada Demam Tifoid Anak

Sari Pediatri, 2016
Telah dilakukan penelitian uji klinis non-komparatif pengobatan cefixime terhadap demam tifoid anak di Bagian Ilmu Kesehatan Anak FKUI-RSCM Jakarta, sejak Mei 1999 – Januari 2000.
Sri Rezeki S Hadinegoro, Alan R Tumbelaka, Hindra Irawan Satari   +2 more
doaj   +1 more source

Combined Use of Cyclodextrins and Amino Acids for the Development of Cefixime Oral Solutions for Pediatric Use

Pharmaceutics, 2021
Cefixime (CEF) is a cephalosporin included in the WHO Model List of Essential Medicines for Children. Liquid formulations are considered the best choice for pediatric use, due to their great ease of administration and dose-adaptability. Owing to its very
Marzia Cirri, Natascia Mennini, Giulia Nerli, Jessica Rubia, Enrico Casalone, Fabrizio Melani, Francesca Maestrelli, Paola Mura   +7 more
doaj   +1 more source

Interpretation of Key Updates in the 36th Edition of Clinical and Laboratory Standards Institute M100 Standard

iLABMED, EarlyView.
ABSTRACT The Clinical and Laboratory Standards Institute M100 document serves as a cornerstone standard for clinical microbiology laboratories in China. Maintaining the scientific rigor of its predecessors, the 36th edition incorporates updated epidemiological cutoff values, pharmacokinetic/pharmacodynamic data, and clinical efficacy evidence to revise
Kanghong Xu, Qi Wang, Hui Wang
wiley   +1 more source

Preparation and Evaluation of Cefixime Nanocrystals

Iraqi Journal of Pharmaceutical Sciences, 2017
Drug nanocrystals are nanoscopic crystals of the parent compound with dimensions less than 1 µm. A decrease in particle size will lead to an increase in effective surface area in the diffusion layer, which, in turn, increases the drug dissolution rate ...
Ahmed A. Hussein, Hasanain Sh. Mahmood
doaj   +3 more sources